Enovix (NASDAQ:ENVX - Get Free Report) is anticipated to issue its Q1 2025 quarterly earnings data before the market opens on Wednesday, May 7th. Analysts expect the company to announce earnings of ($0.18) per share and revenue of $4.72 million for the quarter. Enovix has set its Q1 2025 guidance at -0.210--0.150 EPS.
Enovix (NASDAQ:ENVX - Get Free Report) last issued its quarterly earnings data on Wednesday, February 19th. The company reported ($0.17) EPS for the quarter, topping analysts' consensus estimates of ($0.18) by $0.01. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. The business had revenue of $9.72 million for the quarter, compared to analysts' expectations of $8.77 million. On average, analysts expect Enovix to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Enovix Price Performance
NASDAQ:ENVX traded up $0.11 during trading hours on Friday, hitting $6.59. 4,075,403 shares of the stock were exchanged, compared to its average volume of 6,074,323. The firm's fifty day moving average price is $6.98 and its 200 day moving average price is $9.16. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. The company has a market cap of $1.27 billion, a P/E ratio of -4.54 and a beta of 1.99. Enovix has a 52-week low of $5.27 and a 52-week high of $18.68.
Insider Transactions at Enovix
In other news, CEO Rajendra K. Talluri sold 300,000 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $9.35, for a total transaction of $2,805,000.00. Following the sale, the chief executive officer now directly owns 2,045,301 shares of the company's stock, valued at $19,123,564.35. This represents a 12.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 15.70% of the stock is owned by insiders.
Wall Street Analyst Weigh In
ENVX has been the subject of several research analyst reports. Benchmark lowered their price target on Enovix from $25.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday, April 15th. B. Riley lowered their price objective on shares of Enovix from $17.00 to $12.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. TD Securities reduced their price objective on shares of Enovix from $10.00 to $7.00 and set a "hold" rating for the company in a research note on Thursday, May 1st. Cantor Fitzgerald reissued an "overweight" rating and set a $30.00 price objective on shares of Enovix in a research note on Thursday, February 20th. Finally, Craig Hallum decreased their price objective on shares of Enovix from $20.00 to $18.00 and set a "buy" rating for the company in a research note on Thursday, February 20th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, Enovix currently has an average rating of "Moderate Buy" and a consensus target price of $17.27.
View Our Latest Report on ENVX
About Enovix
(
Get Free Report)
Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
See Also

Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.